Search courses 👉
Professional Training

Supplementary Protection Certificates - Key CJEU Case Law and Pending Referrals - Webinar

Length
0.5 hours
Next course start
Available On-Demand See details
Course delivery
Self-Paced Online
Length
0.5 hours
Next course start
Available On-Demand See details
Course delivery
Self-Paced Online

Course description

Supplementary protection certificates (SPCs) extend the protection conferred by a patent for an approved medicinal product by up to five years and are available in the UK and EU and EEA countries (as well as some other European counties).


Article 3 of the SPC Regulation (469/2009) sets out the criteria required to obtain an SPC. Despite various national Courts having referred multiple questions to the Court of Justice of the European Union (CJEU) as to how the SPC Regulation is to be interpreted, divergent national decisions and recent further referrals to the CJEU, demonstrate that there remains some uncertainty as to the correct interpretation of Article 3.


Presented by Samantha Bullen of Pinsent Masons, this short webinar will provide an update on the recent CJEU case law relating to Article 3 and an overview of the pending referrals.

Upcoming start dates

1 start date available

Available On-Demand

  • Self-Paced Online
  • Online
  • English

Outcome / Qualification etc.

Following all MBL courses, a certificate of attendance will be provided for those who are required to evidence their CPD activity to a professional body.

Training Course Content

Introduction

Supplementary protection certificates (SPCs) extend the protection conferred by a patent for an approved medicinal product by up to five years and are available in the UK and EU and EEA countries (as well as some other European counties).

Article 3 of the SPC Regulation (469/2009) sets out the criteria required to obtain an SPC. Despite various national Courts having referred multiple questions to the Court of Justice of the European Union (CJEU) as to how the SPC Regulation is to be interpreted, divergent national decisions and recent further referrals to the CJEU, demonstrate that there remains some uncertainty as to the correct interpretation of Article 3.

This short webinar will provide an update on the recent CJEU case law relating to Article 3 and an overview of the pending referrals.

What You Will Learn

This webinar will cover the following:

  • What an SPC is and the criteria for obtaining an SPC
  • An overview of the key CJEU decisions, and the most recent case updates, in relation to Article 3 of the SPC Regulation, including:
    • Royalty Pharma (C-650/17); and
    • Santen (C-673/18)
  • An overview of the pending recent referrals to the CJEU from the Finnish and Irish Courts
  • What is next for the SPC regime?

Expenses

From £99
MBL Seminars Limited
C/o Law Business Research
Holborn Gate, 330 High Holborn
WC1V 7QT London

MBL Seminars Limited

With over 1,000 expert speakers covering more than 3,360 different topics, our course portfolio is vast and can be delivered either online or in-person. With over 450 years of collective professional development experience, we are proud to be trusted to...

Read more and show all courses with this provider

Ads